March 21 (Reuters) - Swiss online drug retailer
DocMorris DOCM.S met expectations on Tuesday as it released
its full-year results for 2023, helped by structural cost
savings.
The firm reported a loss in adjusted earnings before
interests, taxes, depreciation and amortization of 34.9 million
euros (about $38 million), in line with expectations for a loss
of 34 million euros, according to a company-compiled consensus.
($1 = 0.9145 euros)
(Reporting by Tristan Veyet and Louis van Boxel-Woolf in
Gdansk; Editing by Mrigank Dhaniwala)
((Tristan.Chabba@thomsonreuters.com;
louis.vanboxel-woolf@thomsonreuters.com))